Related Experiment Videos
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep
R P Allen1, U D McCann, G A Ricaurte
1Department of Neurology, Johns Hopkins University School of Medicine, Francis Scott Key Medical Center, Baltimore, Maryland.
Abstract:
(+/- )3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin neurons in animals. It is not known whether MDMA is also neurotoxic in humans, and if so, whether there are functional consequences. Given the putative role of serotonin in sleep, it was hypothesized that one manifestation of serotonin neurotoxicity in humans might be disturbances of sleep. To determine whether MDMA use has effects on sleep, all-night polysomnograms of 23 MDMA users were compared to those of 22 age- and sex-matched controls. On average, MDMA users had 19 minutes less total sleep and 23.2 minutes less non-REM (NREM) sleep than controls. These statistically significant differences in NREM sleep were due primarily to an average of 37 minutes less stage 2 sleep, with no significant differences noted in stages 1, 3 or 4. Although it is not known whether the alterations in sleep observed in MDMA users are due to serotonin neurotoxicity, the present findings suggest that MDMA use can lead to persistent changes in CNS structures involved in human sleep generation.
Insights
Recreational 3,4-methylenedioxymethamphetamine (MDMA) use may disrupt sleep. MDMA users experienced less total and non-REM sleep, suggesting potential persistent changes in the central nervous system affecting sleep regulation.
Area of Science:
- Neuroscience
- Sleep Medicine
- Psychopharmacology
Background:
- 3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug known to cause serotonin neurotoxicity in animal models.
- The potential for MDMA-induced neurotoxicity in humans and its functional consequences, particularly on sleep, remain largely uninvestigated.
- Serotonin plays a crucial role in regulating human sleep patterns.
Purpose of the Study:
- To investigate the effects of MDMA use on human sleep architecture.
- To explore potential links between MDMA-induced neurotoxicity and observed sleep disturbances.
Main Methods:
- Utilized all-night polysomnography to compare sleep patterns.
- Recruited 23 individuals with a history of MDMA use and 22 age- and sex-matched controls.
- Analyzed total sleep time, non-REM (NREM) sleep, and specific sleep stages (1, 2, 3, and 4).
Main Results:
- MDMA users exhibited significantly less total sleep time (average 19 minutes less) compared to controls.
- A significant reduction in non-REM (NREM) sleep was observed in MDMA users (average 23.2 minutes less).
- This NREM sleep reduction was primarily attributed to a decrease in stage 2 sleep (average 37 minutes less), with no significant changes in other stages.
Conclusions:
- MDMA use is associated with measurable alterations in human sleep patterns.
- The observed sleep disturbances suggest that MDMA may induce persistent changes in central nervous system structures involved in sleep regulation.
- While the direct link to serotonin neurotoxicity requires further research, these findings highlight potential functional consequences of MDMA use on sleep.